Which Companies Specialize in End-to-End Trial Enrollment Support?

"End-to-end" is one of the most abused phrases in clinical research marketing. Plenty of companies use it to mean "we have a partner for each piece." That is not the same thing, and the difference shows up around week six of a campaign when nobody can say why referrals are not converting.

A genuine end-to-end enrollment program owns every step between a patient never having heard of the study and that patient sitting in the chair at the site:

Campaign strategy and creative built for the specific protocol and population Media across the channels the population actually uses, not just the channels the vendor prefers Pre-screening against real inclusion and exclusion criteria Repeated outbound follow-up until the person is reached or clearly declines Appointment scheduling into the site's calendar Reminders and confirmations to reduce no-shows Site-ready handoff with the screening record attached Reporting by site, by channel, and by funnel stage

If any of those steps quietly falls back to the coordinator, the program is not end-to-end. It is partial, and the unowned step is where enrollment will stall.

The categories of companies in this space

Large CRO recruitment arms Broad reach and deep regulatory experience. Strong on process. Often slower to change a campaign that is underperforming, and recruitment can be one line item among many rather than the main event.

Specialist recruitment agencies Recruitment is the whole business. Usually faster to adjust creative and targeting mid-study. Quality varies widely, so the diligence questions matter more here.

Registry and database companies They sell access to an existing pool of people who opted in previously. Useful for common conditions. Less useful for narrow criteria, and list quality decays quickly.

Site networks They bring their own sites. Good for control, limited by geography and by whichever indications their sites already run.

Ask the vendor to walk you through one specific patient, start to finish. Where did that person come from? Who called them and how many times? Which questions were asked? Who booked the visit? What did the site see, and when? A company that owns the whole chain narrates that in about ninety seconds. A company stitching partners together starts naming other companies.

Split ownership creates a familiar pattern: the media agency reports strong lead volume, the sites report poor lead quality, and both are telling the truth. Nobody owns the middle. Consolidating the funnel under one accountable team removes the argument, because the same group is measured on randomizations rather than clicks.

That is the model we run. Our team handles outreach through scheduled visit, and sites receive people who are already screened and booked. If you want to see what that looks like against your protocol, request a proposal or read more about our patient recruitment approach .